ARTICLE | Clinical News
Nasal calcitonin-salmon spray regulatory update
February 23, 2004 8:00 AM UTC
FDA accepted for review an ANDA from NSTK for its calcitonin-salmon nasal spray to treat osteoporosis. NSTK said salmon calcitonin is 40-50 times more potent and has a longer duration of action than ...